The 4th AseBio – TERAV – CIBER Forum examines how to boost value chains in advanced therap... 14/01/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Advanced therapies offer new therapeutic options for complex diseases and also represent a strategic asset due to their... AseBio
The 4th AseBio – TERAV – CIBER Forum examines how to boost value chains in advanced therap... 14/01/2026 Advanced therapies offer new therapeutic options for complex diseases and also represent a strategic asset due to their... AseBio
ISCT 2026 (International Society for Cell & Gene Therapy) Dublin Ireland Del 06/05/2026 to 09/05/2026 Advanced therapies
AseBio welcomes the European institutions’ decision to move forward with the EU pharmaceut... 17/12/2025 Healthcare Drug discovery Rare diseases Innovative drugs Advanced therapies Antibiotic resistance As this legislation has not been amended for more than two decades, we encourage the Commission to be more ambitious in... AseBio
Advanced Therapies Week 2026 San Diego Estados Unidos Del 09/02/2026 to 12/02/2026 Advanced therapies
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Fundación Científica de la Asociación Española Contra el Cáncer Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Integra Therapeutics secures €10.7 million investment round to advance development of FiCA... 08/09/2025 Healthcare Advanced therapies Financing The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI Innvierte (Government... Partners - Integra Therapeutics S.L.
BCN HEALTH publishes a study highlighting the substantial productivity losses associated w... 03/09/2025 Healthcare Access to innovation Advanced therapies BCN HEALTH has published the study “Economic consequences of premature mortality due to brain cancer in Spain: a human... Partners - BCN Health
ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadadem... 25/08/2025 Healthcare Advanced therapies First iadademstat clinical trial in non-malignant hematological indications. Partners - Oryzon Genomics
